Cargando…
Preclinical findings: The pharmacological targets and molecular mechanisms of ferulic acid treatment for COVID-19 and osteosarcoma via targeting autophagy
The variant virus-based 2019 coronavirus disease (COVID-19) pandemic has reportedly impacted almost all populations globally, characterized by a huge number of infected individuals. Clinical evidence proves that patients with cancer are more easily infected with severe acute respiratory disease coro...
Autores principales: | Pang, Guangfu, Yi, Tingzhuang, Luo, Hongcheng, Jiang, Lihe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530469/ https://www.ncbi.nlm.nih.gov/pubmed/36204096 http://dx.doi.org/10.3389/fendo.2022.971687 |
Ejemplares similares
-
Preclinical findings reveal the pharmacological targets of ferulic acid in the treatment of traumatic brain injury
por: Dong, Qinghua, et al.
Publicado: (2022) -
Preclinical In Silico Evidence Indicates the Pharmacological Targets and Mechanisms of Mogroside V in Patients With Ovarian Cancer and Coronavirus Disease 2019
por: Li, Yongming, et al.
Publicado: (2022) -
Preclinical Effectiveness of Selective Inhibitor of IRS-1/2 NT157 in Osteosarcoma Cell Lines
por: Garofalo, Cecilia, et al.
Publicado: (2015) -
Research progress on the pharmacological effects of berberine targeting mitochondria
por: Fang, Xinyi, et al.
Publicado: (2022) -
Exploring novel targets of sitagliptin for type 2 diabetes mellitus: Network pharmacology, molecular docking, molecular dynamics simulation, and SPR approaches
por: Qi, Jian-hong, et al.
Publicado: (2023)